Biography

Jennifer Jarrett has served as a member of our board of directors since September 2018.

Since March 2026, Ms. Jarrett has served as President and Chief Executive Officer of Damora Therapeutics, Inc., a biopharmaceutical company. From October 2020 through March 2026, she served as Chief Operating Officer of Arcus Biosciences, from February 2019 through September 2020, she served as Vice President of Corporate Development and Capital Markets of Uber Technologies and from June 2018 to January 2019 served as Arcus Bioscience’s Chief Operating Officer and Chief Financial Officer and as its Chief Business Officer and Chief Financial Officer from March 2017 to June 2018. From April 2016 to September 2016, Ms. Jarrett was the Chief Financial Officer of Medivation. Before Medivation, Ms. Jarrett spent 20 years in investment banking, most recently at Citigroup where she ran the firm’s west coast life sciences investment banking practice, and prior to that at Credit Suisse and Donaldson, Lufkin & Jenrette. Ms. Jarrett currently serves on the board of directors of Damora, Sagimet Biosciences and Zura Bio, each of which is a publicly traded company, and previously served on the board of each of Arcus Biosciences, Arena Pharmaceuticals and Audentes Therapeutics.

Ms. Jarrett received a B.A. in Economics from Dartmouth College and her M.B.A. from the Stanford Graduate School of Business.